Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |